Friday, August 30, 2013

Perrigo Attains 52- week High - Analyst Blog

Hot Insurance Companies To Buy For 2014

Shares of Perrigo Company (PRGO) soared to a 52-week high of $123.95 during the second half of the trading session on Jul 5, 2013 buoyed by a series of positive developments. The closing price of the company on that day was $123.77, representing an impressive year-to-date return of 16.2%.

Moreover, Perrigo has delivered positive earnings surprises in three of the last four quarters with an average beat of 1.61%. The long-term expected earnings growth rate for this stock is 12.8%.

Acquisition of Fera's Eye-care Portfolio- A Smart Move

Last month, Perrigo purchased the ophthalmic sterile ointment and the solution product portfolio from the privately-held Fera Pharmaceuticals, for approximately $93 million in cash.

The deal, which has strengthened the company's eye-care portfolio, looks good to us. The acquisition has added nine generic prescription drugs to its portfolio. The addition of the generic prescription drugs has further strengthened the company's Rx Pharmaceuticals segment.

Perrigo expects the acquisition to boost its adjusted earnings per share in fiscal 2014 by 12 cents. The company's fiscal year ends on the last Saturday of Jun every year.

Perrigo has lately been quite active on the acquisition front. On Apr 1, 2013, the company announced that it has completed the acquisition of companion animal health company, Velcera, Inc. for approximately $160 million in cash.

In Feb 2013, the company acquired UK-based Rosemont Pharmaceuticals Ltd. By acquiring Rosemont Pharma, Perrigo has strengthened its position in the UK oral liquid formulations space.

In Dec 2012, Perrigo acquired privately held Cobrek Pharmaceuticals, Inc. for approximately $45 million in cash. In Jan 2012, the company inked a deal to acquire the assets of Georgia-based private company CanAm Care, thereby expanding its presen! ce in the diabetes care market. In Jul 2011, it acquired Paddock Labs to expand its generic Rx business. We are impressed by Perrigo's growth-by-acquisition strategy.

Strong Pipeline

We are also impressed by Perrigo's strong pipeline. Perrigo has a strong pipeline and expects to launch more than 60 new products in fiscal 2013 contributing approximately $130 million to revenues.

Other Stocks to Consider

Perrigo, which develops, manufactures and distributes OTC and generic prescription pharmaceuticals, carries a Zacks Rank #3 (Hold) in the short run. Stocks such as Mylan Inc (MYL) appear to be more attractive in the generic space with a Zacks Rank #2 (Buy). Meanwhile, stocks such as Biogen Idec Inc. (BIIB) and Jazz Pharmaceuticals Public Limited Company (JAZZ) appear to be more favorably placed. Both companies carry a Zacks Rank #1 (Strong Buy) and are worth considering.

Wednesday, August 28, 2013

Staples Attains New High - Analyst Blog

On Jul 11, 2013, shares of Staples, Inc. (SPLS) recorded a new 52-week high of $16.70. At the end of the trading session, the stock closed at $16.67, up approximately 47.7% year to date.

The current price is 13.9% above the Zacks Consensus average price target of $14.63. Moreover, the stock is currently trading at a forward P/E of 12.56x, a 30% discount to the peer group average of 17.91. The long-term EPS growth rate stands at 6.9%.

Being a leading retailer of office products and services, we believe Staples remains well positioned to benefit from the sector consolidation that would help it capture incremental market share through rational pricing. The company is poised to generate growth by enhancing its online features, expanding offerings and streamlining its cost structure.

Staples is laying emphasis on improving store productivity, accelerating growth in adjacent categories and increasing market share in core office supplies. Alongside, the company is focusing on the delivery business, which requires less capital and generates higher margins. These factors could prove to be a game changer for the company in the long run.

However, the company continues to disappoint on the sales front as decline in business and consumer spending in the wake of the global meltdown and the deterioration of credit markets have resulted in sluggish demand for big-ticket items.

Going forward, we expect demand for office products to remain soft. Moreover, margins are likely to remain under pressure owing to the company's price investment and macroeconomic headwinds.

Currently, Staples holds a Zacks Rank #3 (Hold). Alongside, companies like Sally Beauty Holdings Inc. (SBH), DSW Inc. (DSW) and Brown Shoe Co. Inc. (BWS) attained new 52-week highs Jul 11, 2013.

Sunday, August 25, 2013

MannKind Surges 16% as Diabetes Drug Completes Trial

A good drug is hard to find. And MannKind (MNKD) just might have found a good one.

AFP

Today, the pharmaceutical company said that a trial showed its inhaled insulin helped diabetes sufferers. Bloomberg has the details:

Afrezza, a powdered form of insulin delivered through an inhaler, was more effective at controlling diabetics' blood sugar levels when combined with oral diabetes medicines compared to those drugs alone, the Valencia, California-based company said today in a statement. The results are from the last stage of testing required to get U.S. regulatory approval. If cleared for sale, the product would be the only inhaled insulin on the market, potentially replacing injections and pumps.

Cowen’s Simos Simeonidis and Yatin Suneja, who rate MannKind Market Perform, pose two questions for investors to consider:

So, assuming it is approved, the question becomes 1) can MannKind find a partner and 2) how much would AFREZZA be used?

Griffin Securities analyst Keith Markey thinks finding a partner is a given:

The data will be submitted by early October, so approval should come by early April. In the interim, Mannkind will seek a marketing partner(s) and a deal could be struck fairly quickly, as the regulatory risk has virtually dissipated. Much will depend on the number of companies involved and the terms offered. Regardless, Mannkind has cleared a key inflection point, and it has adequate financing to get through approval.

Markey rates the stock a Buy with an $11 price target. Shares of MannKind have jumped 14% to $7.85 today. The SPDR Biotech ETF (XBI) has gained 0.7% to $119.85 today, while Alnylam Pharmaceuticals (ALNY) has gained 1% to $49.05, NPS Pharmaceuticals (NPSP) has fallen 4.1% to $23.56, and InterMune (ITMN) has risen 2.6% to $14.89.

Saturday, August 24, 2013

IMF Issues Tepid Forecast, Hints It Does Not Like U.S. Tapering

The International Monetary Fund has lowered its forecast for world economic growth in a generally glum report which states that downside risks dominate growth prospects.

And like a doctor recommending diet and exercise to a patient more accustomed to binge snacking and chronic inactivity, the Washington-based institution also put in a muted good word for structural reform in its quarterly World Economic Outlook, released this week.

The IMF forecasts global growth of 3.1% in 2013, a downward revision from its April forecast of 3.3%, and its 3.8% projection for 2014 is also lower than its April 4% forecast.

The 188-nation organization says slow growth in the U.S. and deceleration in emerging markets—the world’s former economic engines — and a deeper-than-expected recession in the euro area leading to “depressed confidence” — are the primary causes of the world’s underperformance.

The U.S. economy this year is projected to grow at a 1.7% rate, lower than last year’s 2.2% rate, but fueled by rising household wealth resulting from the U.S. housing recovery, the IMF forecasts 2.7% growth next year.

Japan’s easy-money-fueled economy is expected to grow at a 2% rate this year, falling to 1.2% next year.

The euro area is contracting by more than half a percent this year, which growth projected at just under 1% next year.

Emerging-market and developing economies are seen as moderating the more rapid pace of growth that helped balance the world economy in the midst of the financial crisis.

The IMF forecasts 5% growth in 2013 and 5.5% next year for the broad sector, but lowering its April forecast for growth in China—down a quarter and half percentage points respectively from the 7.75% it had projected for 2013 to 2014 in its previous report. Forecasts for all the BRICS countries were also revised downward by one to three quarters of a percentage point.

Altogether, projections for global growth for 2013 to 2014 have come down a quarter of a percent from the IMF’s April forecast. The report says that new risks have been added to old ones, and made note of “temporary uncertainty about the exit from monetary policy stimulus in the United States.”

The report implicitly criticized the Federal Reserve’s new tapering policy — i.e., cessation of bond buying — saying that “with low inflation and sizable economic slack, monetary policy stimulus should continue until the recovery is well established.”

But then in an on-the-one-hand, on-the-other-hand style, the IMF expressed support for monetary easing as a “first line of defense against downside risks,” while acknowledging “potential legacy problems from a prolonged period of rapid credit growth.”

In an overall economic prescription, the world economic institution said “key advanced economies should pursue a policy mix that supports near-term growth, anchored by credible plans for medium-term public debt sustainability.”

Top 10 Energy Companies For 2014

More specifically, it called on China to increase consumption and Germany investment, while urging deficit countries to take measures that increase competitiveness.

---

Check out U.S. Remains Engine of Global Growth: Cerulli

Monday, August 19, 2013

IRFC tax free bonds list on the stock exchanges

RFC in January 2012 issued tax free, secured, redeemable, non-convertible bonds of face value of Rs 1,000 each in the nature of debentures, having benefits under Section 10(15)(iv)(h) of the Income Tax Act, 1961, as amended (bonds) aggregating to Rs 3,000 crore with an option to retain oversubscription of upto the shelf limit of Rs 6,300 crore.

These bonds carry a coupon rate of 8.00% p.a for 10 years (ISEC Comment: Series I) and 8.10% p.a for 15 years (ISEC Comment: Series II). An additional coupon rate of 0.15% p.a. and 0.20% p.a. on series 1 and series 2 respectively shall be available to Resident Indian Individuals, Hindu Undivided Families through the Karta and Non Resident Indians on repatriation as well as non-repatriation basis, applying for an amount aggregating upto and including Rs 5 lakh across all series in the tranche (available only to the original allottees).
 
The bonds have been rated 'CRISIL AAA/Stable' by CRISIL, '[ICRA] AAA' by ICRA and 'CARE AAA' by CARE, indicating highest degree of safety for timely servicing of financial obligations.

SBI Capital Markets Limited, A K Capital Services Limited and ICICI Securities Limited are the Lead Managers to the issue. Indian Bank shall be the Trustee to the issue.

The company intends to utilize the Issue proceeds for financing the acquisition of rolling stock and financing the capacity enhancement works in the Indian Railways.

To read the full report click here

Sunday, August 18, 2013

Moody's Upgraded to Strong Buy - Analyst Blog

On Jul 11, 2013, Zacks Investment Research upgraded Moody's Corp. (MCO) to a Zacks Rank #1 (Strong Buy). With a strong return of 70.4% over the past one year and a positive estimate revision trend, Moody's is an attractive investment opportunity.

Why the Upgrade?

Upbeat first quarter results, strength in new domestic debt issuance and improving clarity over regulatory climate in Europe contributed to the upgrade. Moody's remains a solid franchise in rating debt instruments based on its diversified credit research business model and international growth opportunities.

Moody's reported first quarter earnings of 97 cents per share that were well ahead of the Zacks Consensus Estimate of 87 cents. However, including litigation expenses of 14 cents, earnings were 83 cents per share, up 9.0% from the year-ago quarter.

Revenues surged 13.0% year over year to $731.8 million and exceeded the Zacks Consensus Estimate of $718.0 million. Domestic revenues soared 18.0% year over year to $406.1 million in the reported quarter. International revenues increased 8.0% year over year to $325.7 million in the quarter.

Moody's expects 2013 revenues to grow in the high single-digit percent range. Operating expenses are projected to increase in the mid-single digit percent range. Operating margin is projected to be between 41% and 42%. Earnings for 2013 are expected to be in the range of $3.49 to $3.59 per share.

The Zacks Consensus Estimate for fiscal 2013 increased 2.6% to $3.58 per share as most of the estimates were revised higher over the last 90 days. The current estimate is within the guidance range provided by Moody's. For fiscal 2014, the Zacks Consensus Estimate increased 2.4% to $3.90 per share.

The long-term expected earnings growth rate for Moody's is 13.9%.

Other Stocks to Consider:

Investors can also consider other stocks that are doing well right now. These include Akamai Technologies (AKAM), Energizer Holdings (ENR) and CIT Gro! up (CIT). While Akamai and Energizer carry a Zacks Rank #1 (Strong Buy), CIT carries a Zacks Rank #2 (Buy).

Saturday, August 17, 2013

Further Proof You're Buying The Wrong Dividend ETFs

There are a few certainties when it comes to dividend ETFs. First, investors like these funds. A lot. Inflows data says as much.

For example, the Vanguard Dividend Appreciation ETF (NYSE: SDY) has not been a slouch either in terms of year-to-date inflows with over $1.1 billion.

Another certainty is that by embracing many of the most popular dividend ETFs, investors are committing to a fund that is A) Likely heavy on staples and utilities stocks and B) Probably light on financial services and technology stocks. It is not that the "old school" dividend ETFs are bad. They are not, but there are good reasons to reconsider one's view on dividend ETFs.

For a while, it seemed as though investors had to go off the beaten path to discover that their beloved, old school dividend ETFs were cheating them out of financial services and/or technology exposure. That is undoubtedly shameful because technology has contributed to the majority of S&P 500 dividend growth over the past five years and financial services has been the top dividend raising sector over the past three.

Better later than never, but fortunately, the mainstream media is finally catching on. Technology companies in the Standard & Poor's 500 Index distributed $10.8 billion in dividends in the most recent quarter, up from $5.1 billion in the same period in 2010 and tech companies paid a record $11.9 billion in dividends in the first quarter, Bloomberg reported.

Yes, the average tech company yield is still piddly at just 1.21 percent, but as Bloomberg reports, that is the first time in at least 15 years it has been above 1 percent.

What that confirms is something the astute have long believed: The paradigm must be shifted, if even a little bit, to those dividend ETFs with decent tech sector exposure.

Some investors might say, "Can I just own the Technology Select Sector SPDR (NYSE: XLK) for my tech dividend exposure?" Sure, but that is not the best idea and here's why. XLK is up just over sev! en percent year-to-date. Proving that dividends really do work, the First Trust NASDAQ Technology Dividend Index Fund (NASDAQ: TDIV), which is all of 11 months old, has outpaced XLK by over 500 basis points.

Ten years ago, it was accurate to say Cisco (NASDAQ: CSCO), Intel (NASDAQ: INTC) and Microsoft (NASDAQ: MSFT) were not dividend stocks. These days, that trio representing over 24 percent of TDIV's weight, not only pay dividends, but they raise those payouts, too.

Reconsider Utilities
One of income investors' favorite destinations in the past decade has been the utilities sector. Robust yields and low correlations to the broader market have made made the sector something of a dividend nirvana.

The rush to utilities stocks and ETFs such as the Utilities Select Sector SPDR (NYSE: XLU) has also prompted frothy valuations that are near the high end of the sector's historical average.

This is how investors should be looking at the tech vs. utilities dividend trade off: To embrace the latter group, they will pay more on valuation while likely subjecting themselves to lower rates of future dividend growth. Yes, nearly three-quarters of publicly traded utilities boosted payouts last year, but this year analysts say fewer utility companies are likely to raise their dividends, and those that do will boost them by smaller amounts, according to the Wall Street Journal.

Here is a real world example of how the tech/utilities trade-off has worked with a pair of dividend ETFs over the past three years. SDY, the second-largest U.S. dividend ETF, currently has a 10.1 weight to utilities, by no means the largest among dividend ETFs, and just a 4.3 percent weight to tech. Over the past three years, SDY is up 62.1 percent, including paid dividends.

That sounds great until learning about the WisdomTree Total Dividend Fund (NYSE: DTD). DTD currently has a 13 percent weight to tech, twice the ETF's weight to utilities. Over the past three years, DTD is up 70 percent while b! eing slig! htly less volatile than SDY.

For more on ETFs, click here.

10 Best Cheap Stocks To Invest In Right Now

(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Friday, August 16, 2013

Why it makes sense to start investing early in your career!

Hot Growth Stocks To Watch For 2014

Investing for your retirement may not be the most important thing on your mind when you start your career. For most people, investing may not even be on the priority list when they start their career. When you start your career, your saving capacity may not be much in absolute terms, as your salary itself may not be much. But this should not deter you from making investments. This is because the first few years of your earning life has a huge impact on your future finances.

As with anything else in life, investing also benefits with an early start. The earlier you do your retirement planning, the greater will be your return on investment. There are more reasons than one for you to start investing early in your career. Let's look at the various benefits of early investing.

The effect of compounding:
The most important reason for you to start investing early in your career is to get the benefit of compounding. Compound interest works magic for any investor. As you know, compound interest means the interest earned on interest. If you continuously reinvest your earnings, your return on investment will increase exponentially.

When you regularly invest from the start of your career, you are increasing the return you receive on your returns. A monthly investment of as low as Rs.1,000 or Rs.2,000 will have a large impact on your financial position. Let's understand the effect with a few examples:

Example 1: X is 25 years old and has 35 years left for retirement. He starts to invest Rs. 1000 per month for 35 years at a return of 12% per annum. The corpus left with X at the end of 35 years will be Rs. 64 lakhs.

Y is 30 years old and has only 30 years left for retirement. He also starts to invest Rs. 1000 per month. But as he has started investing late in his career, he can invest this amount only for the next 30 years at 12% per annum. The corpus left with Y at the end of 30 years will be Rs. 35 lakhs. This is the difference 5 years of investment has made to the final corpus value. If Y needs the same Rs. 64 lakhs for his retirement, he will need to shell out Rs.1830 per month instead of Rs. 1000.

To understand the wonder of compounding, let's look at another example:
Example 2: Both X and Y are 30 years of age and have 30 years left for retirement. Now, X invests Rs. 2000 every month for the first 15 years at a return of 12% per annum. He totally invests Rs. 3.6 lakhs. At the end of 15 years of his investment, he does not invest further and also does not withdraw the money. His total corpus at the end of 30 years will be close to Rs. 55 lakhs.

Now Y invests only Rs. 1000 per month at a return of 12% per annum. But he invests for 30 years. Y's total investment is also Rs. 3.6 lakhs - same as X's total investment. But his corpus after 30 years is only Rs. 35 lakhs. Thus for the same total investment, X's corpus is much higher than Y's corpus. This is because X had invested more in the initial years and had allowed this money to get compounded for the total period.

Thus, the most important advantage of beginning to invest early in your career is to realise the full benefits of compounding. There are other reasons why it makes sense to start investing early in your career -

Improvement in spending habits: As you begin to save early in your career to start investing, you have lesser disposable cash with you. This helps you in being more prudent and brings about a discipline in your spending habits.
Ability to take risk: Not all of us get our investment options correct the first time. When you begin exploring investment avenues early in your life, you have a greater ability to take risk and experiment, compared to someone who starts investing later. This is because, at a later stage in life, if you realise you do not have sufficient savings; you will be more cautious in your choice of investments.

Money available during emergencies: When you begin to invest early, you would have a comfortable cushion backing you up. Thus, you can be rest assured that your savings will be of use to you in times of need.

Better choices in life: As seen in the examples above, the corpus built by investing early in life is much bigger than the corpus built by someone who starts a little later. As a result of the savings back-up, you can afford a better lifestyle and an improved quality of life, helping to fulfil your financial goals.
Thus, beginning to invest early in your career can help you in building a secure future.



 


 

BankBazaar.com is an online marketplace where you can instantly get the lowest loan rates , compare and apply online for your personal loan , home loan , car loan and credit card from India's leading banks and NBFCs.

Wednesday, August 14, 2013

Reflections from 20 Years of Investing (2001-2008) Part 3

"We do not learn from experience; we learn from reflecting on experience." — John Dewey

Today's edition will chronicle my investment saga in the final years leading up to the credit crisis which began in the late summer and early fall of 2008. I have decided to forgo describing the investment details of one of my largest successes (Imperial Sugar, formerly IPSU) in favor of describing my temporary diversion from the most important aspect of value investing. Specifically, I will address my failure to maintain a sufficient margin of safety in my investments. Anyone interested in reviewing the investment thesis for Imperial Sugar can access [url=http://www.gurufocus.com/news/156964/principles-of-graham-margin-of-safety-a-practical-application ]this GuruFocus article[/url] which details the "perfect storm" of events that provided the company with a temporary windfall of profits.

Since October of 2002 the family portfolios had climbed steadily, eventually peaking in October of 2007. Many years prior, I had set of goal of becoming a millionaire by the age of 50 — a pipe dream would have provided a better description of my ambition to become wealthy at the time I set the goal. However, by the early months 2006, our accumulative investment portfolios had surpassed that level and the family portfolios would continue to ascend in value for the months which followed.

Unfortunately, the steady appreciation in the market value of our portfolios had begun to take a toll on my approach to risk management. I had started investing large sums of money in companies which carried extremely high levels of long-term debt; that practice had injected an extreme element of downside risk should an economic downturn unfold.

Further, the majority of these companies were theme-related and highly cyclical in nature. This reckless process eliminated any margin for error should the cash flows of the businesses suddenly subside. The family portfolios had become analogous to a stack of perfectl! y aligned dominoes. Should the first domino tip over, the change reaction would be almost certain to eclipse the entire line. Like many other investors, I had failed to recognize the concept of counter-party risk in regard to my investment holdings. It would seem that the author had forgotten about Graham's three most important words in investing: "Margin of Safety."

Successful value investors must first and foremost play defense and let the upside eventually take care of itself. Similar to many sports fans, investors may prefer the excitement that is generated by an offensive approach but long term success is invariably a function of the investor's ability to avoid purchases which result in large, irreversible losses. Chicks may "dig the long ball" but sluggers typically swing and miss far more often than they drive the ball out of the park. In investing, continually "swinging for the fences" constitutes a deadly sin.

Today's edition of Reflections from 20 Years of Investing will not focus upon glory; instead it will examine the perilous nature of investment success which can lead to overconfidence and an abandonment of sufficient risk management.

The Investing Climate in 2007 and 2008

By 2007, large bubbles had developed in the U.S. housing market as well as in other housing markets throughout the world. Further, the price of virtually every commodity had skyrocketed to unsustainable levels. The housing boom and the commodity "super cycle" had temporarily distorted the trailing price to earnings ratios of a plethora of businesses. These bubbles created an illusion that many of the related stocks were still valued-priced in terms of their present earnings as well as their balance sheet values.

Mark to market accounting practices will invariably overstate the equity of financial stocks as well as commodity companies during favorable economic periods (alternatively, the book values of such companies will become decidedly understated as the bubble! bursts).! This phenomenon frequently results in false reads by value investors in regard to the intrinsic value of a company.

In the case of bank stocks, "overstated" balance sheet equity allows the financial institutions to increase their leverage and the level of their outstanding loans, as well as encouraging their officers to engage in risky behavior in the form of proprietary trading practices. Additionally, banks tend to underestimate their loan reserves when all is rosy.

During the housing bubble, lending standards were becoming relaxed and the practice of bundling subprime loans into collateralized debt obligations (CDOs) became a mainstream practice. These securities were backed by highly inflated credit ratings even though the quality of the underlying assets was highly questionable. By 2007, the worldwide demand for this type of asset-backed security (ABS) was beginning to wane and the mortgages which provided the collateral for the securities were starting to come into question.

By the latter part of 2007, U.S. housing inventories were rising to precariously high levels and all the industries which had benefited from the housing bubble were now losing their earnings momentum. Furthermore, the rapid increase in housing prices coupled with undisciplined lending standards had placed many Americans in houses which were well beyond their means.

The problem was further exacerbated by the vast amount of credit default swaps (CDSs) which were written on many of the ABS and CDO that banks and other investment institutions had purchased. The CDSs were purchased in an attempt to hedge the risk of the purchasers in the event that the securities they had invested in would eventually fail.

CDS were intended to be purchased as insurance against defaults (for bonds, ABS, CDO, etc.); however, it was not a necessary condition for investors to own the underlying security in order to purchase the protection. Savvy investors such as John Paulson, who held no investments in any of t! he CDOs, ! were building extensive positions in CDSs on mortgage-related investment securities based upon the belief that the U.S. housing market would soon be in peril. If the housing market collapsed, the payouts on the CDSs would result in hundreds of millions of dollars in gains for the hedge funds.

AIG (AIG), seemingly oblivious to the investment risk, was selling excessive amounts of CDSs as if the derivative contracts were similar to other types of insurance. Apparently, the managers at AIG did not understand the underlying weakness in the bundles of mortgages that they were insuring or the interrelated nature of the various entities.

Their risk was spread out in the other forms of insurance that they wrote and no single catastrophe would be sufficient to bankrupt the entire company. Unfortunately, that would not be the case should a rapid housing collapse trigger a series of defaults on the multitude of mortgage-backed securities which they were recklessly insuring.

Furthermore, countless banks and other financial institutions were heavily invested in many forms of asset-backed securities. They mistakenly believed that the hedges which they laid in place (in the form of credit default swaps) would protect them against any potential defaults in the interest-bearing securities and derivative contracts which they had purchased. What the banks did not foresee was their inability to collect upon the insurance they had purchased in the event of a systemic collapse of the financial system. Such a collapse would become imminent if firms such as AIG (and others who were selling the CDSs) were unable to payout the CDS contracts which they had written. In other words, certain large financial institutions had become "too big to fail" without creating a systemic failure throughout the world economy.

The stock market began to collapse when Lehman Brothers filed for bankruptcy on Sept. 15, 2008. The shock waves reverberated throughout the world markets as virtually every stock would begi! n a downw! ard spiral. The disastrous decline in equity prices would finally bottom approximately six months later in March of 2009.

Investors who steadfastly held their positions in the market would eventually recover their losses; however, many market participants were simply unable to tolerate the seemingly endless days of drops in the quoted prices of their portfolios. Many investors succumbed to the pressure and exited the market after losing a high percentage of their net worth. Most of these timid investors would not return to the market for many years to come. Countless other investors who employed excessive margin were "stopped" out of their positions, permanently losing the majority of their investment funds.

The fall of 2008 marked the end of the housing bubble. It also signaled a sudden and dramatic decline in the prices of most commodities as a wave of worldwide deflation resulted from the impending credit crisis.

The Family Portfolios Take a Shellacking

Anyone who was invested in stocks in late 2008 and early 2009 was virtually assured of sustaining a severe "haircut." Buffett and Munger have pointed out on numerous occasions: One should never invest in stocks if they are not willing to tolerate a 50 percent decline in the market value of their holdings. In the case of the family portfolios, they were easily able to eclipse that amount. The peak-to-trough decline was more along the lines of 60 percent. Oh well, it was fun being a millionaire while it lasted.

Value investors have little control over the market risk of their stock portfolios; what they can control is the non-market risk of their equity investments. In regard to the latter part of the aforementioned statement, I had become woefully deficient.

My selection of stocks was now almost entirely based upon themes. Instead of seeking out value in out-favor-sectors, I had temporarily diverted to the path of attempting to identify investing themes, although I would only purchase a stock if I de! emed it t! o be a bargain. The major themes I had identified were natural gas related stocks, material stocks such as cement companies, and discounted Chinese growth stocks which made their money by selling their products to Chinese consumers. I also owned significant positions in some other purely American companies which included Casey's (CASY) and Gray Television (GTN). Ultimately, Gray Television would turn out to be a colossal failure (more on GTN later).

In retrospect, the problems with aforementioned approaches are quite obvious: Natural gas and material prices were unsustainably high during that period, and virtually every Chinese stock I held shares in would turn out to be a fraud.

The natural gas stocks I owned appeared to be significantly undervalued based upon their reserves, but that assumption would prove to be entirely invalid when natural gas prices began to drop precipitously. Exactly the same was true in the case of my material stocks. The worldwide wave of deflation which resulted from the credit crisis had destroyed the immediate demand for virtually every commodity.

My only consolation was that I was not alone in my miscalculations; even Warren Buffett publicly acknowledged his poor investment in ConocoPhilips (COP) during that period. It seems that "The Oracle" also made a similar error in calculating the intrinsic value of the company based upon unsustainably high oil and gas prices.

The other glaring weakness in my approach was a total lack of appreciation for non-market risk. Specifically, I owned a number of stocks which held excessive debt to equity ratios, in addition to being cyclical in nature. That strategy produced a particularly toxic combination for stocks I held in the months preceding the credit crisis!

Chinese Stocks: The Accounting Pen Is Mightier Than the Sword (Temporarily)

I must shamefully confess that I made a significant amount of money investing in Chinese reverse-merger stocks. It required a number of years for me to fa! thom that! these companies merely invented the numbers which appeared on their financial statements. I should have come to that conclusion earlier since the success stories that the companies penned simply appeared to be too good to be true. Fortunately, I finally received that epiphany before it became evident to everyone else.

Taken at face value, these small Chinese growth companies appeared to be extraordinary value propositions. It was as if a common author had written the script for each individual company. The companies all shared the following characteristics: They sold products which held favorable cultural or demographic significance, their growth would be enhanced by the rising Chinese consumer and the companies demonstrated extraordinary growth in sales and profits while recording incredible returns on capital.

I bought into the phony stories and financial statements, purchasing shares in companies that provided such things as: traditional Chinese medicines, the world's low-cost producer of probiotics, a manufacturer of traditional Chinese seafood snacks (don't knock dried squid until you have tried it), and a low-cost producer of nano precipitated calcium carbonate (NPCC). Try whispering that last one in your sweetheart's ear during a romantic moment.

Most of the Chinese companies that I purchased now reside on the Pink Sheets or have disappeared altogether, but at one time they all traded on major US exchanges. One of them (AOB), even received the honor of ringing the opening bell at the New York Stock Exchange in 2007, and people say that crime does not pay.

It's easy to joke about these "investments" now, but at the time I detected the pervasive nature of the fraud in these Chinese companies, I found no humor in the situation. Rather, I felt violated; I can only imagine the feeling of investors who had maintained their positions to the bitter end.

I feel compelled to tell a story about one of my major fraud successes, Shengdatech (SDTHQ), which now! trades a! t 4 cents a share; it was the NPCC company. In the mid to latter part of 2007 I ended up purchasing a substantial position in the company. I set a series of limit buy orders well under the ask price of SDTH and the stock started a precipitous decline. My last order filled at just over $4 a share as the stock reached its final new 52-week low. I ended up with entirely more shares of the company than I had originally intended due to the fact that I set most of the orders at points which I thought to be unrealistically low.

Suddenly the stock turned upwards and in the course of only a few weeks or months it was trading at nearly $15 a share. I have never wanted to sell a stock so badly, but I did not want to record any more short-term gains in my taxable accounts for the calendar year of 2006. I recall sweating out the final days of 2006, hoping that SDTH would not collapse before the calendar year ended so I could defer my short-term capital gains for another year.

On New Year's Day 2007, while other people were watching football, I was busy setting sell orders on SDTH to be filled on the opening on the first trading day of the new year. As I recall, I did not even bother to use limits. On Jan. 2, 2008, I sold every share of SDTH in the neighborhood of $15 a share. That was the good news; by the end of 2008 the large gains I made in the fraudulent stock were entirely erased by the massive losses that I would encounter by year's end. The only good news was that I had held the stock into 2008, therefore I never became liable for any of the short-term capital gains. You see those capital gains were easily offset by selling shares in my numerous losing propositions which resulted from the market crash that unfolded later on in the year.

For a complete analysis of the Chinese companies which I purchased, see this GuruFocus article.

Gray Television: A Profound Failure

One of my personality flaws was uncovered when I started investing; specifically, I did not easily give up! on a sto! ck when I made a miscalculation. Rather, I would tend to buy more and more shares as the stock declined in value. It is quite typical for the common investor to hold on to a stock until he gets back to even but I was taking it a step farther. I was refusing to give up on my original thesis in the face of evidence that I had made a mistake.

I originally became concerned about the onset of the credit crisis in the late summer of 2008 when I read an article that stated that Berkshire would no longer sell deposit insurance above and beyond the FDIC limits. Until that time Berkshire provided that service for certain banks through its interest in Kansas Surety. The announcement had sent a chill up and down my spine. I wandered what potential disaster Buffett saw on the horizon that would cause him to take such an action.

Shortly after I noticed Buffett's departure from insuring deposits above the FDIC limit and prior to the Lehman Brothers collapse, I decided to sell all the heavily leveraged, economically sensitive stocks which I owned, with one notable exception, Gray Television. Of course the stocks had already tumbled far from their highs as more astute investors had "smelled the rat" much earlier than I had.

The one stock I held which fit the aforementioned conditions was Gray Television, and it was by far my largest holding. I simply refused to give up on my thesis in regard to the company. Realistically, it was already too late to sell as the stock was trading somewhere between $1.50 and $2 a share at the time. In retrospect, I should never have invested in the company (at least at the high price I paid) due to its exorbitant leverage ratio and the valuation metrics it possessed when its enterprise value was taken into consideration.

I liked the stock because of its biannual windfall in the form of political advertisements, the fact it owned the top-rated television stations in college towns, and the concept that local residents would never abandon their tendency to! watch lo! cal news, sports and weather through their favorite channel. Most of all, I coveted the political revenues which provided guaranteed windfalls on an ongoing basis. It seemed to me that GTN possessed a sizable moat and was unlikely to be threatened by any other form of competition.

At the end of 2007, GTN was trading at price in excess of $8 a share; one year later the market valued the company at 40 cents per share. In 12 short months, my top holding had lost 95% of its market value. At that point in time, the main value of my prized holding was in the form of a tax-loss carryforward.

Although the stock would eventually recover in late 2008, its survival was in serious question. The nonpolitical revenues for the business had dropped off a cliff and the company was now in severe danger of violating the covenants of the favorable credit agreement which they had signed earlier in the year. Gray eventually survived by its ability to sell preferred shares which contained escalating dividends, and as the economy began to recover, the company slowly climbed out of the woods.

I made several errors in regard to GTN: First off, I paid too much for the stock by overvaluing its moat and undervaluing the danger of its enormous debt. Secondly, I continued to average down on the stock and I ended up purchasing way too many shares as a percentage of my portfolio. I simply failed to acknowledge the fact that I might have made a mistake.

By the time I saw the writing on the wall, following the collapse of Lehman Brothers, it was too late to sell the stock for anything other than a tax loss. The stock was now trading at about a buck and a half and was continuing its downward ascent. The market had been correct all along and I had been wrong.

Never before had I purchased such a high interest in a single equity and never before had I so abysmally failed on a stock in which I held such a high conviction. I shudder when I think about how many hundreds of thousand of dollars that error cos! t me in t! he long run (I am certain that it cost me at least several points in my long-term CAGR); however, the lesson I learned was probably worth every penny of the losses that I incurred.

Moving Forward and Applying a Margin of Safety

The lessons I learned from the credit crisis and my experience with Gray Television fundamentally changed my investment behavior going forward. Surprising, I started holding fewer stocks, rarely making an investment unless I was willing to commit at least 10 percent of my funds towards a single stock. Additionally, since that time I have rarely purchased a company that does not hold a net cash position, although I have loosened up slightly as the years have passed.

Late 2008 and early 2009 would become a dream come true for value investors — I only wish I had saved some cash on the sidelines. Instead, I traded out of most of my previously held positions in favor of buying better companies which were trading at larger discounts to their intrinsic values. In the process I was able to create some valuable tax-loss carryforwards.

Investors were suddenly able to purchase viable companies which were trading at extreme discounts to their net current assets. The market had become awash with bargains which held legitimate margins of safety. The process accorded me a mild sense of redemption for my past investing sins. The key to redemption for all investors was staying fully invested during the market crash and the thought of raising a penny of cash never crossed my mind as the market continued to plunge.

When Reflections from 20 Years of Investing returns I will discuss some the stocks that allowed the family portfolios to recover from the extensive losses that they incurred during the credit crisis.

Tuesday, August 13, 2013

Are the Shorts Right About Alcoa?

With shares of Alcoa (NYSE:AA) trading at around $8.70, is AA an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let's analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

C = Catalyst for the Stock's Movement

Alcoa is the most shorted stock on the Dow, and that short position has steadily increased. Are the shorts correct about the future direction of Alcoa's stock?

Alcoa has been around since 1888. It’s the world's leading producer of primary aluminum, fabricated aluminum, and aluminum. It's also the world's largest miner of boxite. Alcoa has 60,000 employees in 31 countries.While it has underperformed the market recently, it's not going anywhere.

Investing should be about choosing quality companies and ignoring the timing aspect. However, it can't be denied that investing in Alcoa is all about timing. When the economy is beginning to show improvement, it’s a superb investment. When the economy is beginning to slow, it’s a poor investment. This doesn’t pertain to central bank action propping up the markets.; it pertains to the actual economy.

Revenue has been declining for Alcoa, which makes the bottom line imperative. Alcoa recently announced that it might cutback aluminum production – its reviewing 460,000 metric tons of smelting capacity. Cutbacks are most likely to take place where there are high energy costs and potential for regulatory changes.

Alcoa is still seeing strength in aerospace and autos. Aerospace might continue to see growth, but anyone predicting strong growth in autos is highly optimistic. Consumer discretionary industries aren't likely to perform well in the economic environment ahead.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

The chart below compares fundamentals for Alcoa and Aluminum Corporation of China Limited (NYSE:ACH).

AA ACH
Trailing P/E 37.99 N/A
Forward P/E 11.92 118.89
Profit Margin 1.05% -5.41%
ROE 1.36% -14.78%
Operating Cash Flow 1.66B 328.83M
Dividend Yield 1.40% N/A
Short Position 8.90% N/A

Top 5 Financial Stocks To Invest In 2014

Let's take a look at some more important numbers prior to forming an opinion on this stock.

T = Technicals Are Mixed

Alcoa has performed poorly over three-year and one-year time frames. However, the stock has performed respectably over the past month. The stock is also now trading above its 50-day SMA and 200-day SMA.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!
1 Month Year-To-Date 1 Year 3 Year
AA 5.83% 0.56% -2.98% -28.06%
ACH 8.66% -13.60% -4.63% -55.19%
50-Day SMA 8.37
200-Day SMA 8.60

E = Equity to Debt Ratio Is Normal

The debt-to-equity ratio is close to the industry average of 0.60. Revenue is the big concern here, not debt.

Debt-To-Equity Cash Long-Term Debt
AA 0.53 1.56B 8.92B
ACH 1.84 1.96B 16.61B

E = Earnings Have Been Inconsistent

The good news is that Alcoa has been in the black over the past three years. The bad news is that there was an earnings setback in 2012. Revenue also suffered a setback in 2012. On a quarterly basis, revenue declined while earnings improved year-over-year. Revenue and earnings both declined sequentially.

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in billions 26.90 18.44 21.01 24.95 23.70
Diluted EPS ($) -0.10 -1.23 0.24 0.55 0.18
Quarter Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012 Mar. 31, 2013
Revenue ($) in billions 6.01 5.96 5.83 5.90 5.83
Diluted EPS ($) 0.09 0.00 -0.13 0.2188 0.13

 

Now let's take a look at the next page for the Trends and Conclusion. Is this stock an OUTPERFORM, a WAIT AND SEE, or a STAY AWAY?

T = Trends Do Not Support the Industry

Aluminum prices have declined 33 percent since their peak in 2011. Global demand is questionable at best. As mentioned earlier, aerospace and autos are showing strength, but it would be difficult to see continued strength in autos.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

Conclusion

Shorts aren't shorting this stock because they think it's going BK. They're shorting the stock because they don't think it's the right environment for Alcoa. While shorting a stock like Alcoa isn't recommended, the shorts are correct in regards to their analysis. Simply put, Alcoa performs well when the economy is beginning to strengthen and demand is on the rise. That isn't the case at this point in time.

Friday, August 9, 2013

The Strongest Stocks in the Strongest Markets

Paul Goodwin, editor of Cabot China & Emerging Markets Report, explains his global strategy and highlights some favorite investing ideas, from Latin America to Asia.

Steve Halpern: We are here today with Paul Goodwin, editor of Cabot China & Emerging Markets Report. How are you doing, Paul?

Paul Goodwin: I am fine, thanks.

Steve Halpern: You developed an emerging markets timing system which lets you know whether to be adding to your positions or scaling back. Could you tell us a little about your system, and what the outlook for emerging markets is, based on that?

Paul Goodwin: Sure. The Cabot Market Timing Strategy is based on the idea that it isn't really possible to know what markets are going to do in the future, but we can certainly know what they are doing right now.

We use a 25 and 50-day simple moving average on the particular index that we're using, which, in my case, is the Power Shares Golden Dragon China, and we see if the index is above its 25 and 50-day moving averages, and if those averages are moving up.

So, right now the Power Shares is up at 24.40, the 25-day moving average is down at 22, so we have a nice, strong bull market in Chinese stocks, we have a pretty fair margin there, a very comfortable margin.

So, when we have a situation like this, where the market is definitely bullish, we increase our exposure to emerging market funds, and if the market is down, when it falls below those moving averages, then we reduce our positions somewhat and go to cash.

We don't really have an outlook on what the market is going to do, but this system makes sure that we never miss a bull market and that we never stay heavily invested in a bear market.

Steve Halpern: One interesting point that you've made is that US commentators often allow their ideology to cloud their view of China, which is an area that's the primary focus of yours, but that you have no axe to grind. Could you explain that?

Paul Goodwin: Yeah, I know that there are a lot of people in the same way that, you know, I knew people who went through World War II who would never buy a Volkswagen, in the same way there are people who see China as essentially a communist dictatorship and they say they will never invest there, and you know, I don't want to argue with these people.

I could point out that China has brought more people out of poverty than any country in the past century, but I don't really care. What I'm trying to do is to advise people on how to find the strongest stocks in the strongest emerging markets.

So if people want to be patriotic about it, or if they want to view China as the enemy, as people did, say, with Japan back when it was strong, that's their business, but I'm looking for strong stocks and strong markets.

Steve Halpern: You've also noted that you don't have a country bias when you look globally, and while you do look closely at China, you're also willing to look anywhere within the emerging markets world. Where are you seeing opportunities now?

Paul Goodwin: Well, one stock I kind of like right now is called Mercado Libre (MELI), it's essentially the eBay of Latin America, and its stock has been in an uptrend for awhile, and I think there is great opportunity in Latin America.

But when I say I don't have a country, or even a regional bias, I really don't care where the growth is coming. I don't have projections for what's going to happen in, you know, Turkey, or Kazakhstan, or anything of the sort. I'm looking for strong stocks that are delivering good results.

Steve Halpern: Given that you also do focus on China, for those investors who are willing to invest there, is there a stock you'd mention that you particularly like at this time?

Paul Goodwin: I, you know, I think one that I really like right now is a name that everyone should be familiar with. It's Baidu (BIDU), which generally is—whenever people mention Baidu they generally say—the Google of China.

Baidu does have a commanding lead in the search market in China, but for various reasons the stock, after peaking in 2011, went from 166 about down to 83, and along with a lot of Chinese stocks, they were just out of fashion.

But it's really hard to argue with a company that has, the last three years of revenue growth are 81%, 92%, and 57%, and I think with the stock now trading up around 135, I still think it represents a great value and a great way to play the strength of China.

Steve Halpern: Well, thank you very much for joining us today. We really appreciate your time.

Paul Goodwin: Thank you.

Subscribe to the Cabot China & Emerging Markets Report here…

The expert featured in this column, Paul Goodwin, may or may not own positions in any investment vehicle mentioned here. The views and opinions expressed are his or her own.

Thursday, August 8, 2013

Can James River Coal Earnings Recover?

James River Coal (NASDAQ: JRCC  ) will release its quarterly report on Friday, and the hard-hit coal producer doesn't look likely to escape the big losses that have plagued it for a long time. With analysts seeing James River Coal earnings stuck in the red for the foreseeable future, investors have to wonder how much longer the company can sustain ongoing losses of this magnitude.

James River Coal shares the same story as many of its coal-mining peers, as low natural gas prices hurt coal demand from utilities at the same time that weaker growth in emerging market nations hurt the metallurgical side of the coal business. Unlike larger companies, though, James River Coal doesn't have as many resources to weather an extended downturn in coal. Let's take an early look at what's been happening with James River Coal over the past quarter and what we're likely to see in its quarterly report.

Stats on James River Coal

Analyst EPS Estimate

($1.33)

Year-Ago EPS

($0.74)

Revenue Estimate

$195.07 million

Change From Year-Ago Revenue

(30%)

Earnings Beats in Past 4 Quarters

2

Source: Yahoo! Finance.

Can James River Coal earnings ever improve?
Analysts have actually become slightly less pessimistic in recent months about the prospects for James River Coal earnings, narrowing their loss projections by $0.03 per share for the June quarter and $0.14 for the full 2013 year. But expected losses are still enormous compared to its share price, and the stock has gotten hammered, falling another 25% since early May.

Conditions in the coal market continue to be tough, but many companies are adapting to the difficult situation in the industry. Peabody Energy (NYSE: BTU  ) has benefited from its low-cost coal supplies and has taken advantage of lucrative export markets, where natural gas prices are far less competitive and coal much more popular. Peers Arch Coal (NYSE: ACI  ) and CONSOL Energy (NYSE: CNX  ) have done their best to follow Peabody's lead into the export markets, with Arch signing a deal to give it greater export capacity and CONSOL owning its own terminal in Baltimore. By contrast, James River hasn't really pursued exports as an option, leaving it much more exposed to harsher regulation and plentiful natural gas supplies.

Indeed, at this point, James River is working hard simply to keep itself afloat. In May, the stock soared after the company announced a new financing deal that involved trading out more than $243 million of existing convertible debt for $123 million in new debt. Obviously, the reduction in outstanding principal owed is valuable, but James River had to offer much higher interest rates of 10%, compared to 3.125% and 4.5% on the existing notes, and the prices at which the debt is convertible into stock are also lower. Still, the deal bought James River three extra years on some of the notes before maturity.

Hot Cheap Stocks To Watch Right Now

The big question is whether James River will see improving conditions in coal prices before its debt comes due. Metallurgical coal prices remained much higher than thermal coal, with Energy Information Administration data showing worldwide met coal export prices of about $119 per ton, compared to thermal-coal prices of just $73 per ton. A boost in steel production could send met-coal prices even higher, potentially giving James River the revenue boost it needs to get closer to profitability.

In the James River Coal earnings report, watch closely to see how the recent debt restructuring affected the company's cash situation. With consistent negative cash flow in the past couple of quarters, cash burn will be an important element in determining how long James River can wait for better future conditions.

Coal might be on the way out in the U.S., but record oil and natural gas production is revolutionizing the United States' energy position. Read the Motley Fool's comprehensive look at three energy companies set to soar during this transformation in the energy industry in our special free report, "3 Stocks for the American Energy Bonanza." Don't miss out on this timely opportunity; click here to access your report -- it's absolutely free. 

Click here to add James River Coal to My Watchlist, which can find all of our Foolish analysis on it and all your other stocks.

Tuesday, August 6, 2013

Is Bank of America Stock Prepared for Takeoff?

Since the beginning of the year, Bank of America (NYSE: BAC  ) has cleared up much of the uncertainty that's weighed on its stock. In January, it settled with Fannie Mae to resolve billions of dollars' worth of claims related to the sale of faulty mortgages by Countrywide Financial. In April, it settled multiple securities fraud lawsuits with private investors. And most recently, it came to an agreement with MBIA (NYSE: MBI  ) , resolving one of the most contentious legal battles related to the financial crisis.

In the video below, Motley Fool contributor John Maxfield discusses whether, with these things out of the way, it's reasonable for investors to conclude that Bank of America stock will outperform the market going forward.

Bank of America's stock doubled in 2012. Is there more yet to come? With significant challenges still ahead, it's critical to have a solid understanding of this megabank before adding it to your portfolio. In The Motley Fool's premium research report on B of A, analysts Anand Chokkavelu, CFA, and Matt Koppenheffer, Financials bureau chief, lift the veil on the bank's operations, including detailing three reasons to buy and three reasons to sell. Click here now to claim your copy.

#pitch{ margin-bottom: 15px; }

5 Best Stocks For 2014

More Expert Advice from The Motley Fool
The Motley Fool's chief investment officer has selected his No. 1 stock for the next year. Find out which stock in our brand-new free report: "The Motley Fool's Top Stock for 2013." I invite you to take a copy, free for a limited time. Just click here to access the report and find out the name of this under-the-radar company.

Novadaq On Track To Bring Excellent Growth To Light

With second quarter results in hand, Novadaq (NVDQ) continues to look like a rare med-tech story with both very strong growth and large addressable markets trading at something close to a reasonable valuation. "Reasonable" is a subjective assessment, of course, it will take many years of exceptional growth for Novadaq to earn its valuation, but I believe the company's strong portfolio of surgical imaging technologies can drive that growth.

Fine On Revenue, Light On Margins

It may be an exaggeration to say that the Street only cares about Novadaq's revenue growth today, but it wouldn't be much of an exaggeration. To that end, I expect management's somewhat cautious commentary about the capital equipment environment to give investors more reason for pause than the slight underperformance in gross margin and higher opex spending.

Revenue jumped another 50% this quarter, with product sales up 58%. Novadaq saw strong SPY system sales (revenue up 108%), while disposables were also up a healthy 40% (or about 8% to 9% sequentially).

Gross margin rose about a point, but that was also about a point lower than where many sell-side analysts had modeled the quarter. At this point, that's not enough of a discrepancy to merit much investigation, though it sounds like higher than expected SPY system sales played a role. Novadaq also spent more on SG&A than expected, but this is common to the point of cliché with small-cap med-techs in the process of ramping up their direct sales efforts. All told, the company consumed about $0.6 million in cash from its operations (before net working capital) and that's a more relevant metric to follow for the time being.

Share Continues To Grow In The Core Market, Will Other Markets Follow?

The biggest question for Novadaq right now is whether or not the company can replicate the success it has had with its SPY imaging system in breast reconstruction, helped by marketing partner LifeCell. From 13% penetration at the end of 2012, use! of SPY in breast reconstruction has grown to 15% and management is expecting to hit 20% in 2014 - a critical breakpoint that could see significant incremental adoption.

Because it gives the surgeon a way of visually confirming perfusion, SPY has been shown to lead to significant reductions in complications. Another recent study showed that complication rates fell from over 26% to 5% when SPY was used, resulting in a $3,500/patient cost benefit - suggesting that Novadaq is exceptionally cost-effective (it costs about one-third of its expected complication benefit on a per-procedure basis).

Similar benefits have been shown in other trials using the same technology in surgeries like rectal cancer and gall bladder removal. This is why the company is upping its sales and marketing spending - to support its direct marketing efforts with the Luna (wound care) and Pinpoint (minimally invasive surgery) iterations of the technology. All told, these markets could be worth almost 10x the current breast reconstruction opportunity, so it's worth spending the money in my opinion.

The question is one of adoption. There aren't a lot of comparable systems out there, and Novadaq has a pretty good patent estate, but other companies in the endoscopy (Karl Storz, Olympus, Stryker (SYK), for instance) or imaging space (including GE (GE) and Philips (PHG)) could offer some resistance. There's also the question of status quo - while Novadaq's technology makes a surgeon's life easier (and the outcome more certain), they are creatures of habit and gaining acceptance for new procedures often takes longer than you would think it should.

Adding Technology, But Cautious On Cap Spending

With the quarterly announcement, Novadaq also announced the acquisition of the Trapper surgical imaging system from Digirad (DRAD). The Trapper is essentially a scintigraphy system, and it allows physicians to visualize radionuclide-infused tissue in real time. This could be particularly useful in imaging lymph nodes and ! tumors an! d it is a logical addition to Novadaq's portfolio. While the company didn't pay much ($2 million, plus $1 million in contingent payments and royalties over five years), Novadaq already as a meaningful direct sales launch effort to manage, and there is some risk of the company trying to run before it's able to walk at a steady pace.

On an unrelated note, management did sound some caution on its Firefly product and capex spending in general. Firefly is an imaging technology that uses Novadaq technology on Intuitive Surgical's (ISRG) daVinci robots. It's now shipping on about 80% of Intuitive system, and the recent issues with Intuitive's system placements (and system guidance) have worried some that Novadaq will see spill-over. Novadaq's exposure to Intuitive is largely on the front end, as it gets about $15,000 per placement versus only about $125 per procedure. All told, Firefly is a small part of Novadaq's business (more of an affirmation of the technology than a big near-term revenue opportunity) and I would argue that despite management's caution about capex spending, the 175 SPY systems placed this quarter was a positive sign that hospitals will find the money for the systems they really want.

How Big Can It Get?

If Novadaq were to get complete penetration of its known market opportunities today, that would work out to over $1.5 billion in annual revenue just from the disposable packs. Novadaq is never going to get 100% of course, but then the markets the company addresses are also going to grow over time as minimally-invasive procedures take share from conventional open surgeries.

I'm still looking for Novadaq to post long-term growth of over 40% a year in sales, which is admittedly a very large number, but one that works out to about $750 million in 2022 revenue. I also expect this company to see very solid profitability, with long-term free cash flow margins of 20% or better. On a fully-diluted basis, that works out to about $18 per share today. Were the company's technolo! gy to rea! lly catch on, it's conceivable that Novadaq could double that revenue target by 2022, suggesting fair value into the mid-$20s. All of that said, at around 13x 2014 revenue (on a fully-diluted basis), it may seem harder to some to argue that Novadaq is strikingly cheap today.

The Bottom Line

Novadaq is still very small and very much unproven (though 15% share in breast reconstruction procedures is a good start), and the company absolutely has to deliver with its direct sales effort. I believe they will, though, and while Novadaq is absolutely not a stock for the nervous or risk-averse, I still think there's money to be made over the long-term in Novadaq shares.

Source: Novadaq On Track To Bring Excellent Growth To Light

Disclosure: I have no positions in any stocks mentioned, but may initiate a long position in NVDQ over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. (More...)

Sunday, August 4, 2013

Kellogg Misses on Both Revenue and Earnings

Kellogg (NYSE: K  ) reported earnings on May 2. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 30 (Q1), Kellogg missed estimates on revenues and missed estimates on earnings per share.

Compared to the prior-year quarter, revenue increased. Non-GAAP earnings per share grew. GAAP earnings per share dropped significantly.

Margins dropped across the board.

Revenue details
Kellogg chalked up revenue of $3.86 billion. The 15 analysts polled by S&P Capital IQ hoped for sales of $3.94 billion on the same basis. GAAP reported sales were 12% higher than the prior-year quarter's $3.44 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.99. The 20 earnings estimates compiled by S&P Capital IQ predicted $1.02 per share. Non-GAAP EPS of $0.99 for Q1 were 4.2% higher than the prior-year quarter's $0.95 per share. GAAP EPS of $0.85 for Q1 were 15% lower than the prior-year quarter's $1.00 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 36.1%, 380 basis points worse than the prior-year quarter. Operating margin was 13.0%, 260 basis points worse than the prior-year quarter. Net margin was 8.1%, 230 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
Next quarter's average estimate for revenue is $3.84 billion. On the bottom line, the average EPS estimate is $1.00.

Next year's average estimate for revenue is $15.20 billion. The average EPS estimate is $3.87.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 870 members out of 954 rating the stock outperform, and 84 members rating it underperform. Among 295 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 277 give Kellogg a green thumbs-up, and 18 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Kellogg is hold, with an average price target of $60.65.

Can your portfolio provide you with enough income to last through retirement? You'll need more than Kellogg. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.

Add Kellogg to My Watchlist.

Saturday, August 3, 2013

AmSurg Earnings Up Next

AmSurg (Nasdaq: AMSG  ) is expected to report Q1 earnings on April 24. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict AmSurg's revenues will grow 13.6% and EPS will grow 4.0%.

The average estimate for revenue is $261.4 million. On the bottom line, the average EPS estimate is $0.52.

Revenue details
Last quarter, AmSurg recorded revenue of $244.2 million. GAAP reported sales were 10% higher than the prior-year quarter's $217.5 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, non-GAAP EPS came in at $0.49. GAAP EPS of $0.53 for Q4 were 26% higher than the prior-year quarter's $0.42 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 53.9%, 90 basis points worse than the prior-year quarter. Operating margin was 29.8%, 10 basis points better than the prior-year quarter. Net margin was 7.0%, 80 basis points better than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $1.07 billion. The average EPS estimate is $2.18.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 140 members out of 148 rating the stock outperform, and eight members rating it underperform. Among 49 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 47 give AmSurg a green thumbs-up, and two give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on AmSurg is hold, with an average price target of $28.64.

Is AmSurg the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.

Add AmSurg to My Watchlist.

Thursday, August 1, 2013

U.S. Stocks Rise as Home Prices, Consumer Confidence Jump

You need to enable Javascript to play media on Bloomberg.com

Play
The Top Ten Stocks for May 28

U.S. stocks rose, with the Dow Jones Industrial Average returning to a record, after data showed consumer confidence climbed to the highest level since 2008 and home values jumped the most in seven years.

Eight out of 10 S&P 500 groups advanced. State Street Corp. (STT) added 4.1 percent, pacing gains among financial shares, as Moody's Investors Service lifted its outlook for the U.S. banking system. Merck & Co. added 1 percent after Jefferies & Co. increased the stock to a buy. Tiffany & Co. (TIF) increased 4 percent after reporting first-quarter earnings that beat analysts' estimates.

The Standard & Poor's 500 Index rallied 0.6 percent to 1,660.06 in New York. The benchmark equity gauge pared gains after earlier rising as much as 1.5 percent. The Dow added 106.29 points, or 0.7 percent, to 15,409.39 today. About 6.32 billion shares traded hands on U.S. exchanges today, in line with the three-month average.

"The bottom line is there's been a lot of chatter about how the market's going to respond when the Fed tapers, but home prices are rising, jobless claims are coming down, and the stock market keeps going up," James Paulsen, the Minneapolis-based chief investment strategist at Wells Capital Management, which oversees $325 billion, said by telephone. "People are feeling better. They're noticing this recovery broadening out and firing on more cylinders on a regular basis. They know they're under-allocated to risk assets."

The S&P 500 rebounded from its first weekly decline since April 19. The gauge fell 1.1 percent last week as Federal Reserve Chairman Ben S. Bernanke said the central bank could reduce monetary stimulus if economic conditions continue to improve. Investors weighed the prospect of slower Fed bond-buying with data showing that existing home sales climbed and jobless claims topped estimates. U.S. markets were closed yesterday for a holiday.

Bull Market

The benchmark equity index has advanc! ed 3.9 percent so far in May, for a seventh month of gains. That's the longest winning streak since September 2009. The gauge has surged 145 percent since March 2009, driven by better-than-estimated corporate earnings and three rounds of bond purchases from the Fed.

The Dow has rallied for 20 straight Tuesdays through today, the longest streak since at least 1900, according to data by Schaeffer's Investment Research. The winning streak is the second-longest for any day of the week, following the Dow's gain for 24 straight Wednesdays in 1968, data by Schaeffer's Senior Technical Analyst Ryan Detrick show.

'Can't Justify'

"Investors still clearly believe that we have the Bernanke put well in place on the marketplace," Michael Mullaney, chief investment officer at Fiduciary Trust Co. in Boston, said by phone today. His firm manages about $9.5 billion. "That's what driving everything right now. From a fundamental standpoint, from a macroeconomic standpoint, you can't justify these levels right now. The marketplace is ahead of itself from what we can tell."

U.S. stocks extended gains earlier in the session after a Conference Board report showed consumer confidence climbed in May to the highest level in more than five years. The index rose to 76.2, the strongest since February 2008 and exceeding the highest estimate in a Bloomberg survey of economists.

Separate data showed that house prices rose in the 12 months through March by the most in seven years as the recovery in residential real estate gained momentum. The S&P/Case-Shiller index of property values increased 10.9 percent from March 2012, the biggest 12-month gain since April 2006, after advancing 9.4 percent in February.

The Chicago Board Options Exchange Volatility Index, or VIX (VIX), rose 3.5 percent to 14.48. The equity volatility gauge, which moves in the opposite direction as the S&P 500 about 80 percent of the time, is down 20 percent for the year after jumping 12 percen! t last we! ek.

Banking System

Financial stocks gained 1 percent as a group, after earlier rising as much as 1.9 percent. American Express Co. added 1.2 percent to $76.16 and JPMorgan Chase & Co. rallied 1.8 percent to $54.60.

The KBW Bank Index (BKX) jumped 1.3 percent to the highest level since November 2008, as 22 out of 24 U.S. lenders in the measure advanced. State Street rose 4.1 percent to $67.15.

Moody's changed its outlook for the U.S. banking system to stable after keeping it negative since 2008, saying that the country's economy poses less of a threat. Gross domestic product will grow between 1.5 percent and 2.5 percent through next year, helping banks avoid losses, the New York-based credit-rating company said today in a statement.

Energy shares added 1 percent. Exxon Mobil Corp., the world's largest oil company by market value, climbed 0.9 percent to $92.38.

Drugmaker Rally

Health-care stocks rose 0.9 percent. Merck (MRK) added 1 percent to $47.62. The second-biggest U.S. drugmaker was raised to buy from hold by Jefferies analyst Jeffrey Holford, who also increased his price target to $54 a share from $48, saying "mounting" shareholder pressure may lead to a restructuring.

Tiffany added 4 percent to $79.22. The world's second-largest luxury jewelry retailer reported first-quarter earnings excluding some items of 70 cents a share, surpassing the 53 cent-average estimate of analysts in a Bloomberg survey.

Tesla Motors Inc. rose 14 percent, the most in the Russell 1000 Index, to $110.33. The electric-car maker led by Elon Musk is preparing to announce an expansion of its charger network for its vehicles this week. Musk said May 20 the announcement of the expansion of its so-called supercharger network was being pushed back to this week after the Palo Alto, California-based company repaid a U.S. loan.

Valeant Acquisition

Best Stocks For 2014

Valea! nt Pharma! ceuticals International Inc. (VRX) surged 8.7 percent to a record $91.80 after agreeing to buy Bausch & Lomb Holdings Inc. for $8.7 billion. Canada's largest drugmaker's acquisition of Bausch & Lomb, the eye-care company owned by Warburg Pincus LLC, positions Valeant to compete globally in the growing, specialized ophthalmology market.

Utility companies lost 1.2 percent as a group, after a surge of proposed new plants in the nation's largest wholesale power market caused forward prices to drop. Exelon Corp. tumbled 7.5 percent to $32.04. The Chicago-based company, which is the largest U.S. operator of nuclear reactors, was cut to hold from buy at Deutsche Bank AG.

FirstEnergy Corp. erased 6.5 percent to $39.86 for its biggest decline in four years. The Akron, Ohio-based utility company was cut to neutral from outperform at Credit Suisse Group AG. The power companies, which stood to gain from coal plant retirements, are facing more competition from planned natural gas-fueled facilities and imports from neighboring markets.

5 Best Financial Stocks To Own For 2014

The selling pressure on mREITs continues. As investors voice concerns over firms' ability to navigate a changing interest rate environment, many mREIT stocks have been pummeled.

One of the biggest movers today is Armour Residential REIT (NYSE: ARR  ) , falling over 6% at one point. Two mREITs run by Gary Kain, American Capital Agency (NASDAQ: AGNC  ) and American Capital Mortgage (NASDAQ: MTGE  ) , were also trading lower.

In this video, Motley Fool financial analysts David Hanson and Matt Koppenheffer discuss the mREIT industry and what they will be watching going forward.

The largest player in the mREIT space is Annaly Capital, and there's no question its double-digit dividend is eye-catching. But can investors count on that payout sticking around? With the Federal Reserve keeping interest rates at historically low levels, Annaly has had to scramble to defend its bottom line. In The Motley Fool's premium research report on Annaly, senior analysts Ilan Moscovitz and Matt Koppenheffer uncover the key challenges the company faces and divulge three reasons investors may consider buying it. Simply click here now to claim your copy today!

5 Best Financial Stocks To Own For 2014: Hong Fok Corporation Ltd (H30.SI)

Hong Fok Corporation Limited, an investment holding company, engages in property investment, property development and construction, property management, investment trading, and investment holding and management businesses. It develops retail, commercial, and residential units, as well as sells residential units. The company�s investment properties include International Building, a 12-storey commercial building; the Concourse, a 41-storey office tower block with 2 basements; and Concourse Skyline, a retail unit, as well as a vacant land at Claymore Hill. It is developing Concourse Skyline, a part 4/part 7-storey podium car park and apartments with commercial units on the 1st storey, 2 blocks of part 20/part 28-storey, and part 34/part 40-storey housing a total of 360 residential units and 9 retail units. The company�s development properties also comprise Jewel of Balmoral, a 10-storey residential development; and ten@suffolk, a part 13/part 15-storey residential developme nt. Hong Fok Corporation Limited is based in Singapore.

5 Best Financial Stocks To Own For 2014: Ramco-Gershenson Properties Trust(RPT)

Ramco-Gershenson Properties Trust, a real estate investment trust (REIT), engages in the ownership, development, acquisition, management, and leasing of community shopping centers, single tenant retail properties, and one regional mall in the Midwestern, Southeastern, and Mid-Atlantic regions of the United States. As of December 31, 2007, the company owned interests in 89 shopping centers, which included 65 community centers, 21 power centers, 2 single tenant retail properties, and 1 enclosed regional mall. Ramco-Gershenson Properties has elected to be a taxable REIT for federal income tax purposes. As a REIT, it would not be subject to federal income taxes, if it distributes approximately 90% of its taxable income to its shareholders. The company was founded in 1988 and is based in Farmington Hills, Michigan with additional office in Boca Raton, Florida.

Top Stocks To Buy: Associated Banc-Corp(ASBC)

Associated Banc-Corp, a bank holding company, offers various banking and financial services to individuals and businesses primarily in Wisconsin, Illinois, and Minnesota. Its Banking segment provides loans and deposit products to businesses, governments, and consumers. Its products and services include checking, savings, money market deposit, and IRA accounts, as well as certificates of deposit and safe deposit boxes; and home equity loans and lines of credit, residential mortgage loans and mortgage refinancing, education loans, and personal and installment loans. This segment?s products and services also include business checking accounts, business loans, real estate financing, construction loans, letters of credit, revolving credit arrangements, business credit cards, equipment and machinery leases, night depository, cash management, international banking, check clearing, safekeeping, and other banking-based services. The company?s Wealth Management segment provides va rious fiduciary, investment management, advisory, and corporate agency services for individuals, corporations, small businesses, charitable trusts, endowments, foundations, and institutional investors. This segment also offers life, property, casualty, and credit and mortgage insurance, as well as fixed annuities and employee group benefits consulting and administration services; investment brokerage, variable annuities, and discount and online brokerage services; and trust/asset/investment management, administration of pension, profit-sharing and other employee benefit plans, personal trusts, and estate planning services. The company offers its products through branch facilities, loan production offices, supermarket branches, a customer service call center, an interstate automated teller machine network, and Internet banking services. As of December 31, 2010, its banking subsidiary had 280 offices in approximately 150 communities. The company was founded in 1964 and is base d in Green Bay, Wisconsin.

5 Best Financial Stocks To Own For 2014: Banco Latinoamericano de Comercio Exterior S.A. (BLX)

Banco Latinoamericano de Comercio Exterior, S.A. provides trade financing to commercial banks, middle-market companies, and corporations primarily in Latin America and the Caribbean. The company operates in three segments: Commercial, Treasury, and Asset Management. The Commercial segment offers deposits and loans for foreign trade transactions. This segment also provides various products, services, and solutions relating to foreign trade, which include co-financing arrangements, underwriting of syndicated credit facilities, structured trade financing, asset-based financing in the form of factoring, vendor financing and leasing, and other fee-based services, such as electronic clearing services. The Treasury segment offers liquidity management and investment securities activities, including management of interest rate, liquidity, price, and currency risks. The Asset Management segment provides asset management services, including investment advisory services for funds and managed accounts. This division is involved in trading foreign exchange, interest rate swaps, and derivative products. The company was formerly known as Banco Latinoamericano de Exportaciones, S.A. and changed its name to Banco Latinoamericano de Comercio Exterior, S.A. in June 2009. Banco Latinoamericano de Comercio Exterior, S.A. was founded in 1977 and is headquartered in Panama City, the Republic of Panama.

5 Best Financial Stocks To Own For 2014: The NASDAQ OMX Group Inc.(NDAQ)

The NASDAQ OMX Group, Inc. provides trading, clearing, exchange technology, securities listing, and public company services worldwide. It offers trading across various asset classes, including cash equities, derivatives, debt, commodities, structured products, and exchange traded funds; capital formation solutions; financial services and exchanges technology; market data products; and financial indexes, as well as clearing, settlement, and depository services. The company also provides broker services comprising technology and customized securities administration solutions, such as back-office systems to financial participants. In addition, it offers global listing services; technology solutions for trading, clearing, settlement, and information dissemination; and facility management integration, surveillance solutions, and advisory services, as well as develops and licenses NASDAQ OMX branded indexes, associated derivatives, and financial products. As of December 31, 2010 , a total of 2,778 companies listed securities on The NASDAQ Stock Market. The NASDAQ OMX Group supports the operations of approximately 70 exchanges, clearing organizations, and central securities depositories. The company was formerly known as The Nasdaq Stock Market, Inc. and changed its name to The NASDAQ OMX Group, Inc. in February 2008. The NASDAQ OMX Group, Inc. was founded in 1971 and is based in New York, New York.

Advisors' Opinion:
  • [By Dividend]

    NASDAQ OMX Group (NDAQ) has a market capitalization of $4.07 billion. The company employs 2,503 people, generates revenue of $3.438 billion and has a net income of $383 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $787 million. The EBITDA margin is 22.89 percent (the operating margin is 19.72 percent and the net profit margin 11.14 percent). 

    Financial Analysis: The total debt represents 15.02 percent of the company’s assets and the total debt in relation to the equity amounts to 42.54 percent. Due to the financial situation, a return on equity of 7.98 percent was realized. Twelve trailing months earnings per share reached a value of $1.99. Last fiscal year, the company paid $0.00 in the form of dividends to shareholders. 

    Market Valuation: Here are the price ratios of the company: The P/E ratio is 12.41, the P/S ratio is 1.18 and the P/B ratio is finally 0.86. The dividend yield amounts to 2.11 percent and the beta ratio has a value of 0.84.